Swan Genomics
PrivateLast Round
Grant
Mar 5, 2026
Total Funding Raised
$5.77M
Company Overview
Swan Genomics is a biotechnology company that is developing a novel single-molecule DNA sequencing platform intended to make genomics data more accessible, scalable, and affordable.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Swan Genomics Comps
Public and private peers based on sector, stage, and business model.
Swan Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 5, 2026 | ||||
| Grant | Mar 10, 2025 | ||||
| Pre Seed | Sep 1, 2023 |
Swan Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investible | Pre Seed |
| NSW Government | Grant |
| Proto Axiom | Pre Seed |
| In-Q-Tel | Pre Seed |
| Pacific Channel | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 5, 2026
$320K raised from NSW Government
- May 13, 2025
Grew 30% QoQ from 10 to 13 employees.
Swan Genomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Swan Genomics's valuation, stock price, and market status.
